Intervention

Budesonide

ClinicalTrials.gov intervention label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 49 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials49

Recruiting2

Common conditions24

Lead sponsors shown15

Clinical trials

49 shown

Molecular Signatures Associated With Response to ICS Treatment in Patients With COPD Stratified by Eosinophil LevelsNCT06334575 · 2025-02-12

A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With AsthmaNCT05562466 · 2023-05-11

Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host DiseaseNCT04294641 · 2021-05-10

Replication of the D58 Asthma Trial in Healthcare Claims DataNCT04892732 · 2020-10-29

Nebulized Budesonide Combined With Systemic Corticosteroid in Acute Severe AsthmaNCT04016220 · 2019-05-20

Efficacy Of Doxophylline As A Sparing Treatment For Inhaled Corticosteroids In Mexican Children With AsthmaNCT03879590 · 2019-05-01

Budesonide for Immunosuppression After Liver Transplantation to Reduce Side EffectsNCT03315052 · 2019-01-01

Diesel Exhaust Induces Glucocorticoid ResistanceNCT03615742 · 2018-12-01

A Bioequivalence Pivotal Study of SYN010 HFA Inhaler and Symbicort® 160/4.5 in Healthy Volunteers Without Charcoal BlockNCT04494321 · 2017-06-19

The RECONSTRUCT Study - Reconstructing Disease Mechanisms in AsthmaNCT03034005 · 2017-03-27

A 24-wk Dose Ranging Study to Evaluate the Efficacy and Safety of 4 Doses of a New PDE4 Inhibitor in Patients With COPDNCT02986321 · 2016-12-15

A Bioequivalence Pivotal Study of SYN010 HFA Inhaler and Symbicort® 160/4.5 in Healthy Volunteers With Charcoal BlockNCT02850484 · 2016-03-01

A Study to Compare the Efficacy of Fluticasone Furoate/Vilanterol Inhalation Powder With Usual Inhaled Corticosteroids (ICS)/Long Acting Beta Agonists (LABA) in Persistent AsthmaNCT02446418 · 2015-07-09

Efficacy of Nebulized Pulmicort Respules in Primary Lung Cancer Patients With COPDNCT02504801 · 2015-07-01

An Open-Label Study to Characterize the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and LoperamideNCT02400476 · 2015-02-01

Study to Evaluate Efficacy/Safety of Combination Budesonide/Indacaterol vs Fluticasone/Salmeterol in Patients With COPDNCT02055352 · 2014-05-30

Study to Assess the Efficacy and Safety of Omalizumab Treatment on ICS Reduction for Severe IgE-mediated AsthmaNCT01912872 · 2013-11-11

Asthma Biomarkers for Predicting Response to TherapyNCT01973751 · 2013-11-01

Study of Inhaled RNS60 in Combination With Budesonide to Treat Mild to Moderate AsthmaNCT01511302 · 2012-06-01

Multi-centre Study to Assess the Efficacy and Safety of AZD5423 in COPD Patients on a Background Therapy of FormoterolNCT01555099 · 2012-04-01

Symbicort in Airway Predominant Chronic Obstructive Pulmonary Disease (COPD)NCT01253473 · 2012-04-01

Effects of Symbicort on the Ventilatory KinematicsNCT01712854 · 2012-03-01

Bioavailability Study of SYN006, Pulmicort pMDI and Meptin Air in Healthy Adult.NCT02165046 · 2012-02-01

Role of microRNAs in T Cell-Driven Inflammation in AsthmaNCT01484691 · 2012-01-01

New Breath Actuated MDI Symbicort Compared to Symbicort pMDI and Budesonide pMDI for 12 Weeks Twice a DayNCT01360021 · 2011-11-01

The Use of Inhaled Corticosteroids in the Treatment of Asthma is Children in the Emergency RoomNCT01524198 · 2010-11-01

Improvement of FeNO and FEF25-75 After Inhaled Corticosteroid Treatment of AsthmaNCT01340118 · 2010-05-01

AKITA Inhaled Steroid Suspension for Inhalation (AICS) in Subjects With AsthmaNCT01200108 · 2010-03-01

Trial on the Effect of Budesonide/Formoterol and Inhaled Budesonide Alone on Exercise-Induced AsthmaNCT01070888 · 2010-02-01

Efficacy and Safety of Budesonide Foam for Participants With Active Mild to Moderate Ulcerative Proctitis or ProctosigmoiditisNCT01008423 · 2009-11-20

Efficacy and Safety of Budesonide Foam for Participants With Active Mild to Moderate Ulcerative Proctitis or ProctosigmoiditisNCT01008410 · 2009-11-17

Comparison of Asthma-related Outcomes and Costs in Pediatric Subjects That Received Fluticasone Propionate, Budesonide or Montelukast in a Large Managed Care PopulationNCT01328964 · 2009-06-01

Evaluation of the Efficacy and Safety of a Fixed-dose, Single-capsule Budesonide-formoterol Combination in Uncontrolled AsthmaNCT01676987 · 2009-04-01

Study to Evaluate Efficacy and Safety of Pulmicort Respules in Japanese Adult Asthmatic PatientsNCT00855959 · 2009-02-01

Innate Immune Responses in Chronic Obstructive Pulmonary Disease (COPD) PatientsNCT00826163 · 2009-01-01

CARE Network Maintenance Versus Intermittent Inhaled Steroids in Wheezing Toddlers (MIST)NCT00675584 · 2008-08-01

Phase4/Symbicort® Versus Pulmicort Flexhaler® in African AmericansNCT00702325 · 2008-06-01

Effect of ADC4022 Co-Administered With Budesonide on Pulmonary Inflammation in Subjects With Moderate to Severe COPDNCT00634413 · 2008-02-01

Safety, Tolerability and PD Activity of Inhaled TPI 1020 Versus Inhaled Budesonide in COPD PatientsNCT00483743 · 2007-11-01

Study of Budesonide as an Addition to Standard Therapy in Adult Asthmatics in the Emergency Room.NCT00588406 · 2007-09-01

Predictor for an Additional Benefit of Inhaled Corticosteroid in Patients Treated With Tiotropium for COPDNCT00860938 · 2007-04-01

Safety and Efficacy Study of Budesonide (Pulmicort®) Turbuhaler® in Japanese Children With Bronchial AsthmaNCT00509028 · 2006-12-01

Short- and Long Term Growth in Children With AsthmaNCT00380484 · 2006-09-01

Budesonide in Treating Patients With Lung Nodules at High Risk of Developing Lung CancerNCT00321893 · 2006-01-01

Efficacy & Safety of Symbicort® TURBUHALER® 160/4.5 µg Twice Daily & Pulmicort® TURBUHALER® 200 µg Twice Daily + Theolong® Tablet 200 mg Twice Daily in Japanese Asthmatic PatientsNCT00252785 · 2005-10-01

Effects of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease (COPD)NCT00202189 · 2005-09-01

SHARE - Symbicort and Health Economics in a Real Life EvaluationNCT00259766 · 2004-04-01

Adults With Moderate to Severe AsthmaNCT00642122 · 2003-04-01

Childhood Asthma Management Program (CAMP) Phases I (Trial), II (CAMPCS), III (CAMPCS/2), and IV (CAMPCS/3)NCT00000575 · 1991-09-01

Common conditions

Mapped diseases appearing in these trials

Shared study participation does not establish that this intervention treats a disease.

asthma25 chronic obstructive pulmonary disease14 lung cancer2 proctitis2 proctosigmoiditis2 acute asthma1 glucocorticoid resistance1 status asthmaticus1

Leading sponsors

AstraZeneca 8 Intech Biopharm Ltd. 3 Novartis Pharmaceuticals 3 Bausch Health Americas, Inc. 2 GlaxoSmithKline 2 National Cancer Institute (NCI) 2 Ache Laboratorios Farmaceuticos S.A. 1 Activaero GmbH 1 Bispebjerg Hospital 1 Boston Children's Hospital 1 Brigham and Women's Hospital 1 Cantonal Hospital, Baselland 1 Chiesi Farmaceutici S.p.A. 1 Children´s Clinic, Randers 1 Chungbuk National University 1

Trial status mix

COMPLETED38

UNKNOWN5

TERMINATED3

RECRUITING2

WITHDRAWN1

Phase mix

PHASE317

PHASE415

PHASE29

PHASE15

NA2

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.